Cost-Effectiveness of CT Screening in the National Lung Screening Trial is a research paper published in New England Journal of Medicine (2014). On theSindex it has a DataRank of 17.9. It has been cited 554 times, with 200 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.948
From this paper's citation signal
Citation Network Contribution
17.0
From 200 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 200 citers.
NCI NIH HHS
Grant: P30 CA023108
NCI NIH HHS
Grant: U10 CA180794
NCATS NIH HHS
Grant: UL1 TR001086
NCATS NIH HHS
Grant: KL2 TR001088
NCI NIH HHS
Grant: U01 CA080098
NCI NIH HHS
Grant: U10 CA079778
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: UG1 CA189828
MeSH Terms
Additional file 1 of Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis
Additional file 1 of Conventional Computed Tomographic Calcium Scoring vs full chest CTCS for lung cancer screening: a cost-effectiveness analysis
Additional file 2 of Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controls
Additional file 2 of Data-driven identification of plasma metabolite clusters and metabolites of interest for potential detection of early-stage non-small cell lung cancer cases versus cancer-free controls
Additional file 1 of Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
Additional file 1 of Detection of early-stage lung cancer in sputum using automated flow cytometry and machine learning
Additional file 1 of The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
Additional file 1 of The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
Additional file 2 of The aggregate value of cancer screenings in the United States: full potential value and value considering adherence
Additional file 2 of The aggregate value of cancer screenings in the United States: full potential value and value considering adherence